Renaissance Technologies - KERYX BIOPHARMACEUTICALS INC ownership

KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 154 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q2 2015$2,949,000
+824.5%
295,500
+1480.2%
0.01%
+600.0%
Q1 2014$319,000
-96.8%
18,700
-98.1%
0.00%
-95.8%
Q3 2013$10,000,000991,1000.02%
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Old West Investment Management, LLC 1,068,719$3,633,0001.50%
Abrams Capital Management 9,108,867$30,970,0000.82%
Baupost Group 25,791,678$87,692,0000.67%
Bristol Advisors, LLC 51,100$174,0000.29%
RICE HALL JAMES & ASSOCIATES, LLC 2,228,059$7,575,0000.27%
NEXTHERA CAPITAL LP 200,000$680,0000.13%
LINCOLN CAPITAL CORP 37,280$127,0000.10%
Meridian Wealth Management, LLC 49,600$169,0000.07%
Rubric Capital Management LP 199,883$680,0000.07%
Virtus ETF Advisers LLC 155,009$527,0000.05%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders